Skip to main content
Caplight Logo









Shengshan Asset Management

Shengshan Asset Management

Shanghai, Shanghaiwisdomont.com

Overview

Shengshan Asset Management is a venture capital and private equity firm based in Shanghai, China. It seeks to make investments in healthcare and TMT sectors .

Year Founded

2014

Portfolio Companies

12

Investments

Shengshan Asset Management investments
CompanyDateStageLead
Elpiscience BiopharmaceuticalsDec 2019Series BCo-investor
Beijing Geneplus TechnologyNov 2020Series B ExtensionCo-investor
Curon BiopharmaceuticalDec 2019Series BCo-investor
Shanghai Genext Medical Technology Co., Ltd.Oct 2020StrategicCo-investor
Shanghai Zymetas Medtech Co., Ltd.Oct 2020StrategicCo-investor
Book a demo to see all 12 portfolio companies

For institutional investors. Book with your work email.

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Shengshan Asset Management based?

Shengshan Asset Management is headquartered in Shanghai, Shanghai, China.

When was Shengshan Asset Management founded?

Shengshan Asset Management was founded in 2014.

How many portfolio companies does Shengshan Asset Management have?

Shengshan Asset Management has 12 portfolio companies in Caplight's dataset.

What are some companies in Shengshan Asset Management's portfolio?

Portfolio companies visible on Caplight include Elpiscience Biopharmaceuticals, Beijing Geneplus Technology, Curon Biopharmaceutical, Shanghai Genext Medical Technology Co., Ltd., Shanghai Zymetas Medtech Co., Ltd..

What was Shengshan Asset Management's most recent investment shown here?

Shengshan Asset Management's most recent investment in this portfolio sample was in Beijing Geneplus Technology in 2020.

What sectors does Shengshan Asset Management focus on?

Shengshan Asset Management focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, Mobility, Transportation & Logistics, Frontier & Industrial Tech.

What company stages does Shengshan Asset Management focus on?

Shengshan Asset Management typically invests at the MultiStage stage.

What is Shengshan Asset Management's AUM?

Shengshan Asset Management's assets under management are estimated between $100.0M and $250.0M.

Firmographic Details

HeadquartersShanghai, Shanghai
Year Founded2014

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?